ACLS Algorithms

Advanced Cardiac Life Support — four algorithms with medication protocols per AHA 2020 guidelines.

AHA 2020 Guidelines
⚡ SHOCKABLE RHYTHM — Defibrillation is the priority
1
Initial Assessment

Patient unresponsive, pulseless. VFib or pulseless VTach confirmed on monitor.

  • Start high-quality CPR immediately
  • Give supplemental oxygen
  • Attach monitor/defibrillator
2
⚡ Defibrillation (Shock First)

Charge while CPR continues — do not pause compressions until device is ready.

  • Biphasic: 120–200 J (device-specific)
  • Monophasic: 360 J
  • Clear patient, deliver shock
  • Resume CPR immediately — do not pause to check rhythm
3
IV/IO Access & Medications

Establish access during CPR. Do not interrupt compressions for drug administration.

  • Epinephrine 1 mg IV/IO — give after 2nd shock, then every 3–5 min
  • After 3rd shock: Amiodarone 300 mg IV/IO bolus
  • Consider 2nd dose Amiodarone 150 mg
  • Lidocaine if amiodarone unavailable: 1–1.5 mg/kg IV/IO
4
Cycle: CPR → Rhythm Check → Shock

Every 2 minutes: pause briefly to check rhythm. Minimize interruptions — compressions should resume within 10 seconds.

  • Still VFib/VTach: shock again, resume CPR
  • Organized rhythm: check pulse
  • ROSC: post-cardiac arrest care
5
Advanced Airway

Consider endotracheal intubation or supraglottic airway. Waveform capnography to confirm placement.

  • Once advanced airway placed: continuous compressions at 100–120/min
  • Ventilate at 10 breaths/min (1 breath every 6 sec)
  • ETCO₂ <10 mmHg after 20 min suggests poor prognosis

Medications

DrugDoseRouteNotes
Epinephrine1 mgIV/IO q3–5 minVasoconstrictor; give ASAP for non-shockable, after 2nd shock for VFib
Amiodarone300 mg, then 150 mgIV/IO bolusFirst-line antiarrhythmic; after 3rd unsuccessful shock
Lidocaine1–1.5 mg/kgIV/IOAlternative if amiodarone unavailable; max 3 mg/kg
Magnesium1–2 gIV/IO over 5–20 minFor torsades de pointes

H's (Reversible Causes)

  • Hypovolemia
  • Hypoxia
  • Hydrogen ion (acidosis)
  • Hypo/Hyperkalemia
  • Hypothermia

T's (Reversible Causes)

  • Tension pneumothorax
  • Tamponade (cardiac)
  • Toxins
  • Thrombosis (pulmonary)
  • Thrombosis (coronary)
⚠ NON-SHOCKABLE — DO NOT DEFIBRILLATE
1
Initial Assessment

PEA: organised rhythm on monitor but no palpable pulse. Asystole: flatline (confirm in 2 leads).

  • Start high-quality CPR immediately
  • Supplemental oxygen
2
CPR & NO Shock

These are non-shockable rhythms. Defibrillation will not help — focus on CPR quality and reversible causes.

  • Continuous CPR: 100–120/min, at least 2 inches depth
  • Establish IV/IO access
  • Do not interrupt compressions
3
Medications
  • Epinephrine 1 mg IV/IO — as soon as access established, then q3–5 min
  • Consider advanced airway (ETT or supraglottic)
  • Waveform capnography to confirm airway and gauge CPR quality
4
Aggressively Treat Reversible Causes

PEA is almost always caused by something treatable. Simultaneously search and treat.

  • Hypovolemia → IV fluid bolus
  • Hypoxia → optimize airway/ventilation
  • Tension pneumothorax → needle decompression
  • Cardiac tamponade → pericardiocentesis
  • Toxins → antidote where available
  • Pulmonary embolism → thrombolytics
5
Every 2 Minutes: Rhythm Check
  • Organised rhythm: check pulse immediately
  • ROSC: begin post-cardiac arrest care
  • Shockable rhythm appears: switch to VFib algorithm
  • Still PEA/asystole: continue CPR

Medications

DrugDoseRouteNotes
Epinephrine1 mgIV/IO q3–5 minGive ASAP; first-line for PEA and asystole
Sodium Bicarb1 mEq/kgIV/IOOnly if known hyperkalemia, TCA overdose, or severe acidosis
Calcium Chloride500–1000 mgIV slow pushHyperkalemia, hypocalcemia, Ca²⁺-channel blocker OD

H's

  • Hypovolemia
  • Hypoxia
  • Hydrogen ion
  • Hypo/Hyperkalemia
  • Hypothermia

T's

  • Tension pneumothorax
  • Tamponade
  • Toxins
  • Thrombosis (PE)
  • Thrombosis (MI)
1
Identify & Assess

Bradycardia: HR <60 bpm. Determine if haemodynamically unstable (hypotension, altered mental status, ischaemia, acute heart failure).

  • 12-lead ECG to identify rhythm
  • IV access, continuous monitoring
  • Supplemental O₂ if SpO₂ <94%
2
Identify & Treat Reversible Causes
  • Medications (beta-blockers, Ca²⁺-channel blockers, digoxin)
  • Hypoxia, hypothermia, hyperkalaemia
  • Acute MI (especially inferior MI → AV block)
  • Increased vagal tone
3
If Haemodynamically Unstable
  • Atropine 0.5 mg IV — repeat q3–5 min, max 3 mg total
  • If ineffective: transcutaneous pacing (TCP) — ensure capture, analgesia/sedation
  • Dopamine infusion: 2–20 mcg/kg/min IV
  • Epinephrine infusion: 2–10 mcg/min IV
4
Consider Expert Consultation
  • Transvenous pacing if TCP fails
  • Cardiology consult for complete heart block, new LBBB/RBBB
  • Prepare for invasive pacing

Medications

DrugDoseRouteNotes
Atropine0.5 mg q3–5 min, max 3 mgIVFirst-line; ineffective in 2nd/3rd degree AV block below AV node
Dopamine2–20 mcg/kg/minIV infusionTitrate to response; 2nd-line or concurrent with pacing
Epinephrine2–10 mcg/minIV infusionIf atropine & dopamine ineffective
Isoproterenol2–10 mcg/minIV infusionFor beta-blocker overdose; specialist use

Transcutaneous Pacing (TCP)

Rate: 60–80 bpm. Start at lowest current, increase until capture (electrical + mechanical). Provide analgesia/sedation (morphine or midazolam). Confirm mechanical capture by palpating a pulse.

1
Assess Stability

HR >150 bpm. Assess for haemodynamic instability: hypotension, altered consciousness, ischaemia, pulmonary oedema.

  • 12-lead ECG — is QRS narrow or wide?
  • IV access, continuous monitoring, O₂ if needed
2
Unstable: Synchronised Cardioversion

If haemodynamically unstable and tachycardia is causing the instability — proceed immediately.

  • Sedate if conscious (do not delay if critical)
  • Synchronise (sync) mode — confirm sync markers on each QRS
  • Narrow regular: 50–100 J | AF: 120–200 J | Wide regular: 100 J
  • Increase energy if no conversion
3
Stable Narrow-Complex (SVT)
  • Vagal manoeuvres first: Valsalva, carotid sinus massage
  • Adenosine 6 mg rapid IV push — flush immediately with 20 mL saline
  • If no conversion: Adenosine 12 mg IV
  • If AF/flutter: rate control (diltiazem, metoprolol, verapamil)
4
Stable Wide-Complex (VTach)
  • Regular and monomorphic: Amiodarone 150 mg IV over 10 min
  • Alternative: Procainamide 20–50 mg/min until conversion or max 17 mg/kg
  • Irregular wide-complex (AF+WPW): avoid AV nodal blockers → cardioversion
  • Torsades: Magnesium 1–2 g IV over 5–60 min

Medications

DrugDoseRouteNotes
Adenosine6 mg then 12 mgRapid IV + flushSVT; very short half-life; warn patient of brief chest tightness
Amiodarone150 mg over 10 minIVStable wide-complex VTach; then 1 mg/min infusion
Diltiazem15–20 mg IV over 2 minIVAF/flutter rate control; avoid in WPW, hypotension
Metoprolol2.5–5 mg q5 min (max 15 mg)IVAF/flutter rate control; avoid in bronchospasm, decompensated HF
Magnesium1–2 g over 5–60 minIVTorsades de pointes; hypomagnesaemia
Procainamide20–50 mg/min, max 17 mg/kgIV infusionStable VTach; stop if QRS widens >50%, hypotension

Source: AHA 2020 ACLS Guidelines. Reviewed Sep 2026. Obtain ACLS certification for clinical practice.

Training reference only. Not a substitute for ACLS certification or clinical judgement. Follow your institution's current protocols. Activate emergency services in a real emergency.